Literature DB >> 18440479

Primary osseous tumors of the foot and ankle.

John H Rhee1, Rachel B Lewis, Mark D Murphey.   

Abstract

Primary bone tumors involving the foot or ankle may be imaged, because they are symptomatic or may be found incidentally on imaging studies investigating other causes of pain or swelling. As an uncommon location for malignant bone tumors, lesions within the foot and ankle are subject to misdiagnosis. This article reviews the most commonly encountered primary benign and malignant osseous neoplasms that affect the foot and ankle, emphasizing their characteristic radiologic and MR imaging features to aid in appropriate patient management.

Entities:  

Mesh:

Year:  2008        PMID: 18440479     DOI: 10.1016/j.mric.2008.02.008

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  5 in total

1.  [Tumors of the foot: diagnostics and therapy].

Authors:  A Toepfer; U Lenze; B M Holzapfel; H Rechl; R von Eisenhart-Rothe; H Gollwitzer
Journal:  Orthopade       Date:  2012-07       Impact factor: 1.087

2.  Osteoblastoma-like Osteosarcoma of the Cuboid: A Case Report.

Authors:  Navin L Kumar; Andrew E Rosenberg; Kevin A Raskin
Journal:  J Orthop Surg Res       Date:  2010-08-06       Impact factor: 2.359

3.  Tumours of the talus - A pictorial review.

Authors:  Boo Sl; Saad A; Murphy J; Botchu R
Journal:  J Clin Orthop Trauma       Date:  2020-04-11

Review 4.  Primary tumours of the calcaneus.

Authors:  Litao Yan; Junwei Zong; Jin Chu; Wendong Wang; Mingshu Li; Xianfeng Wang; Mingzhi Song; Shouyu Wang
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

5.  Distribution patterns of foot and ankle tumors: a university tumor institute experience.

Authors:  Andreas Toepfer; Norbert Harrasser; Maximiliane Recker; Ulrich Lenze; Florian Pohlig; Ludger Gerdesmeyer; Rüdiger von Eisenhart-Rothe
Journal:  BMC Cancer       Date:  2018-07-13       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.